This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Biodexa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 5MPA?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	5	0.000935%
Employee Share Scheme	5	0.000935%
Individual Insiders	240	0.0449%
Private Companies	1,368	0.256%
Institutions	55,746	10.4%
General Public	477,283	89.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 4242.8%.

Top Shareholders

Top 25 shareholders own 10.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.35%	Armistice Capital LLC	23,272	€126.4k	1,350%	no data
2.25%	Haitong International Asset Management (HK) Ltd.	12,055	€65.5k	94.1%	0.05%
1.23%	Shamir Capital	6,551	€35.6k	384%	100.0%
0.62%	Point72 Asset Management, L.P.	3,324	€18.1k	0%	no data
0.48%	Millennium Management LLC	2,553	€13.9k	456%	no data
0.33%	UBS Asset Management AG	1,789	€9.7k	14,800%	no data
0.27%	Jarvis Securities plc, Asset Management Arm	1,470	€8.0k	0%	no data
0.25%	Anson Group	1,354	€7.4k	0%	0.01%
0.12%	Treasure Sea Limited	649	€3.5k	0%	no data
0.12%	A&B (HK) Company Limited	649	€3.5k	0%	no data
0.088%	Two Sigma Securities, LLC, Asset Management Arm	473	€2.6k	0%	no data
0.08%	Walleye Capital LLC	429	€2.3k	-68.3%	no data
0.07%	A J Bell Holdings Limited, Asset Management Arm	373	€2.0k	0%	no data
0.068%	Turner Pope Investments (TPI) Ltd, Asset Management Arm	364	€2.0k	0%	0.88%
0.059%	Barclays Bank PLC, Wealth and Investment Management Division	314	€1.7k	0%	no data
0.041%	Arthur Morton	219	€1.2k	0%	no data
0.04%	HBOS Investment Fund Managers Limited	213	€1.2k	0%	no data
0.038%	Baader Bank AG, Asset Management Arm	203	€1.1k	0%	no data
0.033%	Cantor Fitzgerald Asset Management	179	€972.2	0%	no data
0.029%	Marex Spectron Group Limited, Asset Management Arm	154	€836.3	0%	0.07%
0.015%	IG Group Holdings Plc, Asset Management Arm	81	€439.9	0%	no data
0.012%	Citigroup Inc.,Banking and Securities Investments	65	€353.1	0%	no data
0.012%	Wings Establishment	64	€347.6	0%	no data
0.012%	Argon Financial Limited, Asset Management Arm	62	€336.8	0%	no data
0.01%	BNP Paribas, Private & Investment Banking Investments	56	€304.0	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/09/27 09:38
End of Day Share Price	2023/06/30 00:00
Earnings	2022/12/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biodexa Pharmaceuticals Plc is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Aydin Huseynov	Ladenburg Thalmann & Company
Savvas Neophitou	Panmure Liberum Historic (Panmure Gordon)
Jens Lindqvist	Singer Capital Markets